Global Critical Care Therapeutics Market 2021-2025

Global Critical Care Therapeutics Market 2021-2025

Technavio has been monitoring the critical care therapeutics market and it is poised to grow by $ 888.68 mn during 2021-2025 progressing at a CAGR of 5% during the forecast period. Our report on critical care therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high demand for albumin in China and increasing surgical procedures. In addition, high demand for albumin in China is anticipated to boost the growth of the market as well.

The critical care therapeutics market analysis includes drug class segment and geographical landscapes.

Technavio's critical care therapeutics market is segmented as below:

By Drug Class

  • Albumin
  • Antithrombin
  • Prothrombin complex
  • Factor XIII
  • Fibrinogen
By Geographical Landscapes
  • North America
  • Europe
  • Asia
  • ROW
This study identifies growing preference for marketed products over alternative treatment options as one of the prime reasons driving the critical care therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on critical care therapeutics market covers the following areas:
  • Critical care therapeutics market sizing
  • Critical care therapeutics market forecast
  • Critical care therapeutics market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading critical care therapeutics market vendors that include Baxter International Inc., Bristol-Myers Squibb Co., CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Novartis AG, Octapharma AG, Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.. Also, the critical care therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
    • Value chain analysis
      • Table Value Chain Analysis: Pharmaceuticals Market
      • Research and development (R&D) and drug discovery:
      • Integration and product development:
      • Manufacturing:
      • Outbound logistics:
      • Marketing and sales:
      • Support services:
  • Market Sizing
    • Market definition
      • The role of plasma therapeutics in the critical care industry
      • Introduction to plasma therapeutics
        • Table Offerings of vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2020
    • Market outlook: Forecast for 2020 - 2025
      • Table Global - Market size and forecast 2020 - 2025 ($ million)
      • Table Global market: Year-over-year growth 2020 - 2025 (%)
  • Five Forces Analysis
    • Fiver forces analysis
      • Table Five forces analysis 2020 & 2025
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2020
  • Market Segmentation by drug class
    • Market segments
      • Table Drug class - Market share 2020-2025 (%)
    • Comparison by Drug class
      • Table Comparison by Drug class
    • Albumin - Market size and forecast 2020-2025
      • Table Albumin - Market size and forecast 2020-2025 ($ million)
      • Table Albumin - Year-over-year growth 2020-2025 (%)
    • Antithrombin concentrates - Market size and forecast 2020-2025
      • Table Antithrombin concentrates - Market size and forecast 2020-2025 ($ million)
      • Table Antithrombin concentrates - Year-over-year growth 2020-2025 (%)
    • Prothrombin complex concentrates - Market size and forecast 2020-2025
      • Table Prothrombin complex concentrates - Market size and forecast 2020-2025 ($ million)
      • Table Prothrombin complex concentrates - Year-over-year growth 2020-2025 (%)
    • Factor XIII concentrates - Market size and forecast 2020-2025
      • Table Factor XIII concentrates - Market size and forecast 2020-2025 ($ million)
      • Table Factor XIII concentrates - Year-over-year growth 2020-2025 (%)
    • Fibrinogen concentrates - Market size and forecast 2020-2025
      • Table Fibrinogen concentrates - Market size and forecast 2020-2025 ($ million)
      • Table Fibrinogen concentrates - Year-over-year growth 2020-2025 (%)
    • Market opportunity by Drug class
      • Table Market opportunity by Drug class
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2020-2025 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2020- 2025
      • Table North America – Market size and forecast 2020-2025 –($ million)
      • Table North America - Year-over-year growth 2020-2025 (%)
    • Europe - Market size and forecast 2020-2025
      • Table Europe - Market size and forecast 2020-2025 ($ million)
      • Table Europe - Year-over-year growth 2020-2025 (%)
    • Asia - Market size and forecast 2020-2025
      • Table Asia - Market size and forecast 2020-2025 ($ million)
      • Table Asia - Year-over-year growth 2020-2025 (%)
    • ROW - Market size and forecast 2020-2025
      • Table ROW - Market size and forecast 2020-2025 ($ million)
      • Table ROW - Year-over-year growth 2020-2025 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ million)
  • Drivers, Challenges, and Trends
    • Market drivers
      • High demand for albumin in China
      • Increasing surgical procedures
      • Growing preference for marketed products over alternative treatment options
    • Market challenges
      • Existence of plasma fractionation supply and demand gap
      • Spread of pathogenic contaminants
      • High regulations of plasma products
        • Table Impact of drivers and challenges
    • Market trends
      • Increased development of recombinant products for critical care use
      • Establishment of plasma fractionation facilities in emerging economies by global players
      • Strategic initiatives of vendors fueling the market growth
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Industry risks
      • Table Industry risks
    • Competitive scenario
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Baxter International Inc.
      • Table Baxter International Inc. - Overview
      • Table Baxter International Inc. - Business segments
      • Table Baxter International Inc. - Key news
      • Table Baxter International Inc. - Key offerings
      • Table Baxter International Inc. - Segment focus
    • Bristol-Myers Squibb Co.
      • Table Bristol-Myers Squibb Co. - Overview
      • Table Bristol-Myers Squibb Co. - Product and service
      • Table Bristol-Myers Squibb Co. - Key news
      • Table Bristol-Myers Squibb Co. - Key offerings
    • CSL Ltd.
      • Table CSL Ltd. - Overview
      • Table CSL Ltd. - Business segments
      • Table CSL Ltd. - Key news
      • Table CSL Ltd. - Key offerings
      • Table CSL Ltd. - Segment focus
    • Grifols SA
      • Table Grifols SA - Overview
      • Table Grifols SA - Business segments
      • Table Grifols SA - Key news
      • Table Grifols SA - Key offerings
      • Table Grifols SA - Segment focus
    • Kedrion Spa
      • Table Kedrion Spa - Overview
      • Table Kedrion Spa - Product and service
      • Table Kedrion Spa - Key news
      • Table Kedrion Spa - Key offerings
    • LFB SA
      • Table LFB SA - Overview
      • Table LFB SA - Product and service
      • Table LFB SA - Key news
      • Table LFB SA - Key offerings
    • Novartis AG
      • Table Novartis AG - Overview
      • Table Novartis AG - Business segments
      • Table Novartis AG - Key news
      • Table Novartis AG - Key offerings
      • Table Novartis AG - Segment focus
    • Octapharma AG
      • Table Octapharma AG - Overview
      • Table Octapharma AG - Product and service
      • Table Octapharma AG - Key news
      • Table Octapharma AG - Key offerings
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Key news
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. - Segment focus
    • Takeda Pharmaceutical Co. Ltd.
      • Table Takeda Pharmaceutical Co. Ltd. - Overview
      • Table Takeda Pharmaceutical Co. Ltd. - Product and service
      • Table Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook